OBJECTIVE: Obesity is associated with increased plasma levels of plasminogen-activator inhibitor-1 (PAI1), the major fibrinolysis inhibitor. PAI1 levels are also increased at menopause, a condition that is associated with fat mass gain, especially in the abdominal area. DESIGN: We hypothesized that genetic variations within PAI1 gene are related to the amount of body fat and its regional distribution. We genotyped 666 subjects of the Quebec Family Study for five PAI1 gene polymorphisms. Stratified analyses were performed with analysis of covariance in men (n = 280) and women (n = 386) separately. RESULTS: PAI1-675 4G/5G polymorphism was strongly associated with body mass index (P < or = 0.01) and fat mass (P < or = 0.05) in women. The PAI1-675 4G/5G promoter polymorphism and the c.43G<A (p.A15T, rs6092) variant within the exon 1 were associated with abdominal visceral fat but only in postmenopausal women (P < or = 0.05). More specifically, homozygotes for the -675 5G and the 43A alleles had about 50% more visceral fat compared to carriers of the -675 4G allele as well as carriers of the 43G allele. No association was observed in men. CONCLUSION: Taken together, these results suggest that the PAI1 gene is associated with obesity and may modulate the changes in adipose tissue distribution generally observed at menopause.
OBJECTIVE:Obesity is associated with increased plasma levels of plasminogen-activator inhibitor-1 (PAI1), the major fibrinolysis inhibitor. PAI1 levels are also increased at menopause, a condition that is associated with fat mass gain, especially in the abdominal area. DESIGN: We hypothesized that genetic variations within PAI1 gene are related to the amount of body fat and its regional distribution. We genotyped 666 subjects of the Quebec Family Study for five PAI1 gene polymorphisms. Stratified analyses were performed with analysis of covariance in men (n = 280) and women (n = 386) separately. RESULTS:PAI1-675 4G/5G polymorphism was strongly associated with body mass index (P < or = 0.01) and fat mass (P < or = 0.05) in women. The PAI1-675 4G/5G promoter polymorphism and the c.43G<A (p.A15T, rs6092) variant within the exon 1 were associated with abdominal visceral fat but only in postmenopausal women (P < or = 0.05). More specifically, homozygotes for the -675 5G and the 43A alleles had about 50% more visceral fat compared to carriers of the -675 4G allele as well as carriers of the 43G allele. No association was observed in men. CONCLUSION: Taken together, these results suggest that the PAI1 gene is associated with obesity and may modulate the changes in adipose tissue distribution generally observed at menopause.
Authors: Jianying He; Duc Son Le; Xiaoyuan Xu; Michael Scalise; Anthony W Ferrante; Jonathan Krakoff Journal: Eur J Endocrinol Date: 2009-11-24 Impact factor: 6.664
Authors: Mingkuan Lin; Christoph J Griessenauer; Robert M Starke; R Shane Tubbs; Mohammadali M Shoja; Paul M Foreman; Nilesh A Vyas; Beverly C Walters; Mark R Harrigan; Philipp Hendrix; Winfield S Fisher; Jean-Francois Pittet; Mali Mathru; Robert H Lipsky Journal: Mol Genet Genomic Med Date: 2019-07-03 Impact factor: 2.183
Authors: Ju Eun Lim; Moo Suk Park; Eun Young Kim; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Se Kyu Kim; Hyo Sup Shim; Byoung Chul Cho; Joon Chang Journal: Tuberc Respir Dis (Seoul) Date: 2013-10-29
Authors: Alexandra Maștaleru; Sabina Alexandra Cojocariu; Andra Oancea; Maria Magdalena Leon Constantin; Mihai Roca; Ioana Mădălina Zota; Irina Abdulan; Cristina Rusu; Roxana Popescu; Lucian Mihai Antoci; Cristian Gabriel Ciobanu; Alexandru Dan Costache; Elena Cojocaru; Florin Mitu Journal: J Pers Med Date: 2022-03-09